Elanix Biotechnologies AG (FRA:ELN) EV-to-EBIT : -1.39 (As of Sep. 20, 2024)

Elanix Biotechnologies AG EV-to-EBIT Chart

Elanix Biotechnologies AG Annual Data
	Trend	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18
EV-to-EBIT		Get a 7-Day Free Trial					0.18	-4.88	-11.66	-6.76	-3.20

Elanix Biotechnologies AG Semi-Annual Data
	Dec08	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18
EV-to-EBIT	Get a 7-Day Free Trial															-11.66	-	-6.76	-	-3.20

Competitive Comparison of Elanix Biotechnologies AG's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Elanix Biotechnologies AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elanix Biotechnologies AG's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elanix Biotechnologies AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elanix Biotechnologies AG's EV-to-EBIT falls into.

Elanix Biotechnologies AG EV-to-EBIT Calculation

Elanix Biotechnologies AG's EV-to-EBIT for today is calculated as:

Elanix Biotechnologies AG's current Enterprise Value is €4.81 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2018 was €-3.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG  (FRA:ELN) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Elanix Biotechnologies AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2018 is calculated as:

Elanix Biotechnologies AG's Enterprise Value for the quarter that ended in Dec. 2018 was €11.05 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Elanix Biotechnologies AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2018 was €-3.46 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elanix Biotechnologies AG EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Elanix Biotechnologies AG's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Elanix Biotechnologies AG Business Description